Maternal serum glycosylated fibronectin as a point-of-care biomarker for assessment of preeclampsia

Medicine & Life Sciences

• glycosylated fibronectin 100%
• Point-of-Care Systems 55%
• Pre-Eclampsia 48%
• Biomarkers 31%
• Mothers 31%
• Serum 22%
• Intercellular Signaling Peptides and Proteins 11%
• Gestational Age 8%
• ROC Curve 8%
• Vascular Endothelial Growth Factor Receptor-1 6%
• Confidence Intervals 5%
• Third Pregnancy Trimester 5%
• First Pregnancy Trimester 5%
• Pregnancy Outcome 4%
• Standard of Care 4%
• Pregnant Women 3%
• Newborn Infant 3%
• Blood Pressure 3%
• Pregnancy 2%